SG3 Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SG3 Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,000	Closed	-$336K	–	1090
2020 Q2	$336K	Buy	+3,000	New	+$295K	0.02%	428

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

SG3 Management's XBI Position: Q3 2020 in Review

SG3 Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2020, closing a stake of 3,000 shares — an estimated $336K sold.

SG3 Management first reported a position in XBI in Q2 2020 and held it in 1 quarter. The position peaked at $336K in Q2 2020. 554 funds tracked by Wall St. Rank hold XBI as of Q3 2020.

SG3 Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2020 after selling out during the quarter.
SG3 Management sold 3,000 State Street SPDR S&P Biotech ETF shares in Q3 2020, an estimated $336K.
SG3 Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 1 quarter.
SG3 Management's State Street SPDR S&P Biotech ETF position peaked at $336K in Q2 2020.
554 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2020.

Based on SG3 Management's 13F filing for Q3 2020, filed 13 Nov 2020.